More articles from Commentary

You have access
Advanced Virus Detection Technologies Interest Group (AVDTIG): Efforts on High Throughput Sequencing (HTS) for Virus Detection
Arifa S. Khan, Dominick A. Vacante, Jean-Pol Cassart, Siemon H. S. Ng, Christophe Lambert, Robert L. Charlebois and Kathryn E. King

PDA Journal of Pharmaceutical Science and Technology November 2016, 70 (6) 591-595; DOI: https://doi.org/10.5731/pdajpst.2016.007161
You have access
Risk Management in Biologics Technology Transfer
Robert Toso, Jonathan Tsang, Jasmina Xie, Stephen Hohwald, David Bain and Derek Willison-Parry

PDA Journal of Pharmaceutical Science and Technology November 2016, 70 (6) 596-599; DOI: https://doi.org/10.5731/pdajpst.2016.006718
You have access
A Biopharmaceutical Industry Perspective on the Control of Visible Particles in Biotechnology-Derived Injectable Drug Products
Serge Mathonet, Hanns-Christian Mahler, Stefan T. Esswein, Maryam Mazaheri, Patricia W. Cash, Klaus Wuchner, Georg Kallmeyer, Tapan K. Das, Christof Finkler and Andrew Lennard

PDA Journal of Pharmaceutical Science and Technology July 2016, 70 (4) 392-408; DOI: https://doi.org/10.5731/pdajpst.2015.006189
You have access
BPOG Response to Annex 2
Jeff Blake, David Estapé, Ken Green, Kavita Ramalingam Iyer, Jeff Johnson, Phil Mcduff, Marc Pelletier, Alan Powell, Scott Probst, Paul Smock, Robin Payne and Tim Corbidge

PDA Journal of Pharmaceutical Science and Technology May 2016, 70 (3) 300-311; DOI: https://doi.org/10.5731/pdajpst.2016.006502
You have access
A Roadmap for the Implementation of Continued Process Verification
Marcus Boyer, Joerg Gampfer, Abdel Zamamiri and Robin Payne

PDA Journal of Pharmaceutical Science and Technology May 2016, 70 (3) 282-292; DOI: https://doi.org/10.5731/pdajpst.2015.006395
You have access
Retrospective Evaluation of Low-pH Viral Inactivation and Viral Filtration Data from a Multiple Company Collaboration
John Mattila, Mike Clark, Shengjiang Liu, John Pieracci, Thomas R. Gervais, Eileen Wilson, Olga Galperina, Xinfang Li, David Roush, Konstantin Zoeller, Helene Brough and Christelle Simpson-Platre

PDA Journal of Pharmaceutical Science and Technology May 2016, 70 (3) 293-299; DOI: https://doi.org/10.5731/pdajpst.2016.006478
You have access
A Review of the Aging Process and Facilities Topic
Maik W. Jornitz

PDA Journal of Pharmaceutical Science and Technology July 2015, 69 (4) 553-556; DOI: https://doi.org/10.5731/pdajpst.2015.01061
You have access
Moving Forward towards Standardized Analytical Methods for Extractables and Leachables Profiling Studies
Dennis Jenke

PDA Journal of Pharmaceutical Science and Technology July 2015, 69 (4) 471-476; DOI: https://doi.org/10.5731/pdajpst.2015.01089
You have access
Drug Shortages, Today and Tomorrow—An Industry Perspective
Sandra Cha Sifferlen

PDA Journal of Pharmaceutical Science and Technology July 2015, 69 (4) 557-561; DOI: https://doi.org/10.5731/pdajpst.2015.01066
You have access
Quality Culture vs. Cost of Quality—Quality Culture Is Understanding the Value, not Just the Price, of Quality
Juergen Knoebel

PDA Journal of Pharmaceutical Science and Technology July 2015, 69 (4) 562-565; DOI: https://doi.org/10.5731/pdajpst.2015.01067

Main menu

User menu

Search

More articles from Commentary

Pages

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.